Support Alert

National Patient Safety Alert - Shortage of alteplase and tenecteplase injections

The Department of Health and Social care has published a National Patient Safety alert for the shortage of alteplase and tenecteplase injections. There will be supply constraints facing alteplase (Actilyse®) 10mg, 20mg and 50mg injections for the remainder of 2022. Tenecteplase (Metalyse®) 10,000unit injections will go out of stock in the coming months. At present the situation is expected to improve in early 2023.

Further information including stock availability and actions required can be found on the CAS website

Loading...

Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up